CD8A and melanoma: In a small study, Sabbatino et al. demonstrated that the number of infiltrating CD8+ and FOXP3+ T cells, as well as the CD8+/FOXP3+ T cell ratio, can be used as prognostic biomarkers in thin melanoma.